Primary Tumor Necrosis Predicts Distant Control in Locally Advanced Soft-Tissue Sarcomas After Preoperative Concurrent Chemoradiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 76, Issue 4, 2010, Pages 1147-1153

  MacDermed, Dhara M ^a   Miller, Luke L ^b   Peabody, Terrance D ^a   Simon, Michael A ^a   Luu, Hue H ^a   Haydon, Rex C ^a   Montag, Anthony G ^a   Undevia, Samir D ^a   Connell, Philip P ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Chemotherapy; Necrosis; Radiation therapy; Sarcoma; Surgery

Indexed keywords

ADJUVANT CHEMOTHERAPY; CONCURRENT CHEMORADIOTHERAPY; DISTANT METASTASIS; IFOSFAMIDE; LOCAL CONTROL; NECROSIS; PATHOLOGIC RESPONSE; RADIATION THERAPY; SOFT TISSUE; SURVIVAL RATE; SYSTEMIC THERAPY; TUMOR NECROSIS; UNIVERSITY OF CHICAGO;

CHEMOTHERAPY; CONCURRENCY CONTROL; PATHOLOGY; RADIOTHERAPY; SURGERY;

TUMORS;

IFOSFAMIDE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; HUMAN; LIMB AMPUTATION; LIMB TUMOR; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; REOPERATION; SOFT TISSUE SARCOMA; SURGICAL WOUND; TUMOR NECROSIS; TUMOR VOLUME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CISPLATIN; DOXORUBICIN; DRUG ADMINISTRATION SCHEDULE; EPIRUBICIN; EXTREMITIES; FEMALE; HUMANS; IFOSFAMIDE; MALE; MIDDLE AGED; NECROSIS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SARCOMA; SURVIVAL RATE; TUMOR BURDEN; YOUNG ADULT;

EID: 77449125878     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.03.015     Document Type: Article

References (30)

1. Zahm S.H., and Fraumeni Jr. J.F. The epidemiology of soft tissue sarcoma. Semin Oncol 24 (1997) 504-514
2. Coindre J.M., Terrier P., Guillou L., et al. Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas: A study of 1240 patients from the French Federation of Cancer Centers Sarcoma Group. Cancer 91 (2001) 1914-1926
3. Heise H.W., Myers M.H., Russell W.O., et al. Recurrence-free survival time for surgically treated soft tissue sarcoma patients. Multivariate analysis of five prognostic factors. Cancer 57 (1986) 172-177
4. Suit H.D., Mankin H.J., Wood W.C., et al. Preoperative, intraoperative, and postoperative radiation in the treatment of primary soft tissue sarcoma. Cancer 55 (1985) 2659-2667
5. Rosenberg S.A., Tepper J., Glatstein E., et al. The treatment of soft-tissue sarcomas of the extremities: Prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy. Ann Surg 196 (1982) 305-315
6. Harrison L.B., Franzese F., Gaynor J.J., et al. Long-term results of a prospective randomized trial of adjuvant brachytherapy in the management of completely resected soft tissue sarcomas of the extremity and superficial trunk. Int J Radiat Oncol Biol Phys 27 (1993) 259-265
7. Yang J.C., Chang A.E., Baker A.R., et al. Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol 16 (1998) 197-203
8. Pollack A., Zagars G.K., Goswitz M.S., et al. Preoperative vs. postoperative radiotherapy in the treatment of soft tissue sarcomas: A matter of presentation. Int J Radiat Oncol Biol Phys 42 (1998) 563-572
9. Mundt A.J., Awan A., Sibley G.S., et al. Conservative surgery and adjuvant radiation therapy in the management of adult soft tissue sarcoma of the extremities: Clinical and radiobiological results. Int J Radiat Oncol Biol Phys 32 (1995) 977-985
10. Davis A.M., O'Sullivan B., Turcotte R., et al. Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma. Radiother Oncol 75 (2005) 48-53
11. O'Sullivan B., Davis A., Turcotte R., et al. Five-year results of a randomized phase III trial of pre-operative vs post-operative radiotherapy in extremity soft tissue sarcoma. Presented at the Annual Meeting of the America Society of Clinical Oncology, held June 5-8, 2004 in New Orleans. J Clin Oncol 22 (2004) 9007
12. Gortzak E., Azzarelli A., Buesa J., et al. A randomised phase II study on neo-adjuvant chemotherapy for 'high-risk' adult soft-tissue sarcoma. Eur J Cancer 37 (2001) 1096-1103
13. Grobmyer S.R., Maki R.G., Demetri G.D., et al. Neo-adjuvant chemotherapy for primary high-grade extremity soft tissue sarcoma. Ann Oncol 15 (2004) 1667-1672
14. Eilber F.C., Rosen G., Eckardt J., et al. Treatment-induced pathologic necrosis: A predictor of local recurrence and survival in patients receiving neoadjuvant therapy for high-grade extremity soft tissue sarcomas. J Clin Oncol 19 (2001) 3203-3209
15. Eilber F.R., Morton D.L., Eckardt J., et al. Limb salvage for skeletal and soft tissue sarcomas. Multidisciplinary preoperative therapy. Cancer 53 (1984) 2579-2584
16. Eilber F.R., Giuliano A.E., Huth J.F., Weisenburger T.H., and Eckhardt J. Intravenous (IV) vs. intraarterial (IA) Adriamycin, 2800r radiation and surgical excision for extremity soft tissue sarcomas: A randomized prospective trial (Abstract). Proc Am Soc Clin Oncol 9 (1990) 309a
17. Wanebo H.J., Temple W.J., Popp M.B., et al. Preoperative regional therapy for extremity sarcoma. A tricenter update. Cancer 75 (1995) 2299-2306
18. DeLaney T.F., Spiro I.J., Suit H.D., et al. Neoadjuvant chemotherapy and radiotherapy for large extremity soft-tissue sarcomas. Int J Radiat Oncol Biol Phys 56 (2003) 1117-1127
19. Kraybill W.G., Harris J., Spiro I.J., et al. Phase II study of neoadjuvant chemotherapy and radiation therapy in the management of high-risk, high-grade, soft tissue sarcomas of the extremities and body wall: Radiation Therapy Oncology Group Trial 9514. J Clin Oncol 24 (2006) 619-625
20. Ryan C.W., Montag A.G., Hosenpud J.R., et al. Histologic response of dose-intense chemotherapy with preoperative hypofractionated radiotherapy for patients with high-risk soft tissue sarcomas. Cancer 112 (2008) 2432-2439
21. Mack L.A., Crowe P.J., Yang J.L., et al. Preoperative chemoradiotherapy (modified Eilber protocol) provides maximum local control and minimal morbidity in patients with soft tissue sarcoma. Ann Surg Oncol 12 (2005) 646-653
22. Levine E.A., Trippon M., and Das Gupta T.K. Preoperative multimodality treatment for soft tissue sarcomas. Cancer 71 (1993) 3685-3689
23. Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: Meta-analysis of individual data. Sarcoma Meta-analysis Collaboration. Lancet 350 (1997) 1647-1654
24. Lorigan P., Verweij J., Papai Z., et al. Phase III trial of two investigational schedules of ifosfamide compared with standard-dose doxorubicin in advanced or metastatic soft tissue sarcoma: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study. J Clin Oncol 25 (2007) 3144-3150
25. Kaplan E.L., and Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 457-481
26. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50 (1966) 163-170
27. Choong P.F., Nizam I., Ngan S.Y., et al. Thallium-201 scintigraphy-A predictor of tumour necrosis in soft tissue sarcoma following preoperative radiotherapy?. Eur J Surg Oncol 29 (2003) 908-915
28. O'Sullivan B., Davis A.M., Turcotte R., et al. Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: A randomised trial. Lancet 359 (2002) 2235-2241
29. Hall E.J. Radiobiology for the radiologist. 5th ed. (2000), Lippincott Williams & Wilkins, Philadelphia
30. Kane J.M., Harris J., Kraybill W.G., et al. RTOG 0330: A pilot phase II study of preoperative radiation therapy/thalidomide for low-grade primary soft tissue sarcoma or preoperative MAID/thalidomide/radiation therapy for high/intermediate grade primary soft tissue sarcoma of the extremity or body wall. Presented at the Annual Meeting of the America Society of Clinical Oncology, held May 30-June 3, 2008 in Chicago. J Clin Oncol 26 suppl (2008) 10536 (Abstract)